[CAS NO. 66663-91-0] Polygalacin D

Ships within

Stock

Price

Qty

Total

$0.00

Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis

request a quote

If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [66663-91-0]

Catalog

HY-N6064

Brand

MCE

CAS

66663-91-0

DESCRIPTION [66663-91-0]

Overview

MDL	MFCD28009141
Molecular Weight	1209.32
Molecular Formula	C57H92O27
SMILES	O[C@H]([C@@H]([C@@H](O[C@@]1([H])[C@@H]([C@H]([C@H](O)CO1)O[C@@]2([H])[C@@H]([C@](CO)(O)CO2)O)O)[C@H](C)O3)O)[C@]3([H])O[C@H]([C@H]([C@@H](O)CO4)O)[C@@H]4OC([C@]56[C@](CC(C)(C)CC6)([H])C7=CC[C@@]([C@@]8([C@@]([C@](C)([C@@H](O[C@]9([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]9O)CO)[C@@H](O)C8)CO)([H])CC%10)C)([H])[C@]%10(C)[C@]7(C)C[C@H]5O)=O

For research use only. We do not sell to patients.

1 Publications Citing Use of MCE

[1]Free Radic Biol Med. 2020 Dec 8;S0891-5849(20)31642-7.

Summary

Polygalacin D (PGD) is a bioactive compound isolated from Platycodon grandiflorum with anticancer and anti-proliferative properties. PGD suppresses the expression of the IAP family of proteins including survivin , cIAP-1 and cIAP-2 and blocks the PI3K/Akt pathway by inhibiting the phosphorylation of GSK3β, Akt and the expression of PI3K . Polygalacin D induces apoptosis ^[1]

IC50 & Target

IC50: IAP ^[1]

In Vitro

Polygalacin D (0-40 µM; 48 hours) inhibits cell proliferation with IC ₅₀ s of 26.49 µM in the A549 cells and 20.52 µM in the H460 cells ^[1] .
Polygalacin D (0-20 µM; 48 hours) increases the proportion of early and late apoptotic cells, and nuclear condensation is observed in A549 and H460 cells ^[1] .
Polygalacin D (0-20 µM; 48 hours) may exerts its apoptotic effects by regulating the apoptotic proteins and the IAP family of proteins in A549 and H460 cells ^[1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay ^[1]

Cell Line:	A549 and H460 cancer cell lines
Concentration:	10 µM, 20 µM, 40µM
Incubation Time:	48 hours
Result:	Inhibited the proliferation of NSCLC cell lines.

Apoptosis Analysis ^[1]

Cell Line:	A549 and H460 cancer cell lines
Concentration:	10 µM, 20 µM
Incubation Time:	48 hours
Result:	Induced apoptosis of NSCLC cell lines.

Western Blot Analysis ^[1]

Cell Line:	A549 and H460 cancer cell lines
Concentration:	10 µM, 20 µM
Incubation Time:	48 hours
Result:	Decreased survivin, c-IAP-1 and c-IAP-2 expression.

Appearance

Solid

Source

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL ( 82.69 mM ; Need ultrasonic)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	0.8269 mL	4.1346 mL	8.2691 mL
5 mM	0.1654 mL	0.8269 mL	1.6538 mL
10 mM	0.0827 mL	0.4135 mL	0.8269 mL

* Please refer to the solubility information to select the appropriate solvent.

In Vivo:

1.

Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

Solubility: ≥ 2.5 mg/mL (2.07 mM); Clear solution
2.

Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

Solubility: ≥ 2.5 mg/mL (2.07 mM); Clear solution
3.

Add each solvent one by one: 10% DMSO >> 90% corn oil

Solubility: ≥ 2.5 mg/mL (2.07 mM); Clear solution

* All of the co-solvents are available by MCE.

References

[1] Seo YS, et al. Polygalacin D induces apoptosis and cell cycle arrest via the PI3K/Akt pathway in non-small cell lung cancer. Oncol Rep. 2018 Apr;39(4):1702-1710.

Synonyms

Olean-12-en-28-oic acid, 3-(β-D-glucopyranosyloxy)-2,16,23-trihydroxy-, O-D-apio-β-D-furanosyl-(1→3)-O-β-D-xylopyranosyl-(1→4)-O-6-deoxy-α-L-mannopyranosyl-(1→2)-α-L-arabinopyranosyl ester, (2β,3β,4β,16α)-

Polygalacin D